William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
YETI Holdings, Inc. Announces Pricing of Initial Public Offering
-
NAIC to Honor Former Illinois Senate President Emil Jones Jr., Ariel's John Rogers and Others at Conference
-
Arix Bioscience plc - LogicBio Announces Closing of Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
William Blair Downgrades Astec Industries (ASTE) to Market Perform
-
PlacementTracker Publishes Q3 2018 Private Placement Market League Tables
-
NeoGenomics (NEO) Reports Acquisition of Genoptix for $125M in Cash & 1M Common Shares
-
NeoGenomics Signs Definitive Agreement to Acquire Genoptix
-
NeoGenomics Signs Definitive Agreement to Acquire Genoptix
-
Frontier Capital Completes Sale of Zephyr
-
Clearlake Capital to Acquire symplr
-
Potomac Equity Partners Announces Sale of Orion, Achieving 7.5x Multiple of Invested Capital and 74% IRR for Investors
-
UPDATE: William Blair Upgrades Syneos (SYNH) to Outperform
-
Krystal Biotech (KRYS) Prices 3M Share Offering at $20/Sh
-
Arix Bioscience plc: LogicBio Prices Nasdaq IPO
-
LogicBio Therapeutics Announces Pricing of Initial Public Offering
-
LogicBio Therapeutics Announces Pricing of Initial Public Offering
-
Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) Commences $60M Public Offering of Common Stoc
-
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
-
William Blair Upgrades Infosys Ltd. (INFO:IN) (INFY) to Market Perform
-
Form D William Blair Emerging
-
Bertram Capital Completes Sale of Spireon to Greenbriar Equity Group
-
The Hill Investment Group Joins William Blair’s Private Wealth Management Team
-
William Blair Assumes Coverage on 8x8 (EGHT), Upgrades to Outperform
-
Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
UPDATE: William Blair Starts Boot Barn (BOOT) at Outperform
-
William Blair Assumes ANSYS (ANSS), Downgrades to Market Perform
-
Valtech SE (VTEC) Announces Proposed 6.67M IPO Between $14-$16/Sh
-
William Blair Downgrades Beacon Roofing Supply (BECN) to Market Perform
-
Valtech SE Announces Proposed Launch of Initial Public Offering
-
Pre-Open Movers 10/05: (SGH) (EMKR) (PLX) Higher; (HSGX) (KMPH) (CUTR) Lower (more...)
-
UPDATE: William Blair Starts QuinStreet, Inc. (QNST) at Outperform
-
Guardant Health (GH) IPO Opens 46% Higher
-
UPDATE: William Blair Starts National Vision Holdings (EYE) at Outperform
-
Guardant Health Inc. (GH) Prices 12.5M Share IPO at $19/Sh
-
Guardant Health Announces Pricing of Initial Public Offering
-
Guardant Health Announces Pricing of Initial Public Offering
-
Sponsors Announced for the 2019 ICR Conference
-
William Blair Continues Expansion of Fixed Income Team
-
THL Credit Announces Public Offering of Notes due 2023
-
THL Credit Announces Public Offering of Notes due 2023
-
THL Credit Announces Public Offering
-
THL Credit Announces Public Offering
-
William Blair Upgrades Euronet Worldwide (EEFT) to Outperform
-
BTIG Adds Amanda Murphy, CFA, as a Managing Director and Senior Biotechnology Equity Analyst
-
UPDATE: William Blair Starts The KEYW Holding Corporation (KEYW) at Outperform

